Allied Academies has been instrumental in conducting international meetings for 25 years, and very excited to expand in medical and healthcare fields. Previous meetings were held majorly in North American cities like San Francisco, Chicago, Las Vegas and expanding to Europe, America and Asia Pacific continents.
With the success of the previous continental conferences we proudly bring International Congress on Drug Discovery and Development to be held during November 02 -03, 2017 at Chicago, USA.
Track 1: Drug Discovery and Innovative Drug Discovery
Drug discovery is the process through which potential new medicines are recognized and comprises an extensive range of scientific disciplines, including biology, chemistry and pharmacology. The integration of pharmacodynamics and pharmacokinetic parameters in non-clinical pharmacology studies is a key characteristic in drug discovery for efficacy and safety assessment, in the particular for the translation from the non-clinical to clinical field and process of drug discovery include the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy where as modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity, efficacy/potency, metabolic stability, and oral bioavailability. The "final product" of drug discovery is a patent on the potential drug.
The global market for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, CAGR of 13.8% between 2012 - 2017.
Track 2: Drug Discovery and Development
The pharmaceutical sector, a foundation of the healthcare sector, is undergoing extensive change, essentially caused by lower output of new medicines from research and development (R&D) laboratories, drug pricing pressures, stricter regulatory environments and the overall current economic recession. This sorts strains of all pharmaceutical firms to find better ways to raise their yield of new drugs, complete improvement, to equally treat patients and happen their shareholders assumption.
Track 3: Nanotechnology in Drug Discovery
Nanotechnology is a study of science and technology which targets to regulate matter at the atomic, molecular, and macromolecular level. New nanotechnologies could bring intense increases in the sensitivity of detection technology for research and diagnostic applications, improved imaging technologies, greater selectivity for drug delivery, and detailed insight into biological mechanisms and systems. Nano biosensors and Nano biochips are used to develop drug discovery and development. Nano scale assays can subsidize substantially to cost-saving in screening promotions. The practise of Nano scale delivery vehicles prominent to the discovery of optimally safe in talling to effective drug candidates, current and promising applications of Nano medicine include, drug delivery, in vitro diagnostics, in vivo imaging, therapy techniques, biomaterials, and tissue engineering .As recognition of the importance of this moving field, it is estimated that the global market of Nano scale applications in medical field might grow to $70 - $160 bn.
According to BCC Research, the global market for nanoparticles in life sciences is assessed at over $29.6 bn for 2014. This market is assessed to raise to more than $79.8 bn by 2019, to record a strong CAGR of 22%.